In his first term, President Trump pledged to boost HIV spending, with the lofty goal of bringing the epidemic to heel by 2030. Now, however, Republicans are seeking deep cuts to HIV funding.
Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, the better, as restarting and staying on HIV treatment can help them reach ...
Former President Bill Clinton opened the annual meeting of the Clinton Global Initiative Wednesday with a list of things that worry him.
Two Indian generic drugmakers – Hetero and Dr Reddy’s – will be funded by the Gates Foundation and Unitaid, respectively, to produce and sell the twice-a-year anti-HIV shot at around R692 per person ...
Drug can be used to prevent catching the virus and treat those who have it Kampala, Uganda | THE INDEPENDENT & AGENCIES | A new long-acting medicine that could make preventing HIV transition might ...
Calgary-based virtual pharmacy PurposeMed is completing its U.S. expansion this month, bringing its popular Freddie service for HIV prevention and treatment to all 50 states.
Wits University's Advanced Drug Delivery Programme has found a way to make treatment as easy as putting on a plaster, changing the way many treat HIV, especially for children in rural communities.
For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even curing—the disease a seemingly insurmountable obstacle to achieve.
Gilead has agreed to provide the drug at cost and to share its intellectual property with generic manufacturers who can produce it at scale ...
The U.S. Department of State announced a life-saving development to bring U.S.-based Gilead Sciences' breakthrough drug lenacapavir to market in Uganda, one of just ten high-burden HIV countries where ...
Cork and Kerry share one HIV clinic, which is 'stretched', Cork Sexual Health Centre's fast-track cities programme manager Tara Russell told the 'Irish Examiner' ...
Year's supply of injectable to cost Rs 3,549, compared to over Rs 17 lakh in US. Powerful alternative to daily oral PrEP, will overcome issues of adherence, stigma, daily access to pills.